LexAurum Advisors’s Thermo Fisher Scientific TMO Stock Holding History

LexAurum Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Sell	405 -288	-42%	-$138K	0.02%	408
2026 Q1	$341K	Buy	+693	New	+$376K	0.04%	303
2025 Q3	$378K	Sell	778 -11	-1%	-$5.12K	0.05%	253
2025 Q2	$320K	Buy	789 +22	+3%	+$9.2K	0.05%	261
2025 Q1	$381K	Buy	767 +3	+0.4%	+$1.63K	0.07%	227
2024 Q4	$398K	Buy	764 +159	+26%	+$87.4K	0.08%	211
2024 Q3	$374K	Hold	605	–	–	0.08%	205
2024 Q2	$335K	Hold	605	–	–	0.08%	208
2024 Q1	$351K	Hold	605	–	–	0.09%	200
2023 Q4	$321K	Buy	605 +1	+0.2%	+$484	0.08%	214
2023 Q3	$306K	Hold	604	–	–	0.09%	211
2023 Q2	$315K	Hold	604	–	–	0.09%	192
2023 Q1	$348K	Sell	604 -152	-20%	-$85.7K	0.12%	163
2022 Q4	$416K	Hold	756	–	–	0.15%	140
2022 Q3	$383K	Hold	756	–	–	0.15%	148
2022 Q2	$411K	Buy	756 +3	+0.4%	+$1.65K	0.15%	137
2022 Q1	$445K	Hold	753	–	–	0.15%	141
2021 Q4	$502K	Sell	753 -8	-1%	-$5K	0.16%	138
2021 Q3	$435K	Buy	761 +8	+1%	+$4.39K	0.13%	180
2021 Q2	$380K	Hold	753	–	–	0.11%	198
2021 Q1	$343K	Buy	753 +1	+0.1%	+$477	0.12%	184
2020 Q4	$350K	Hold	752	–	–	0.13%	173
2020 Q3	$332K	Hold	752	–	–	0.14%	152
2020 Q2	$273K	Hold	752	–	–	0.15%	153
2020 Q1	$213K	Hold	752	–	–	0.15%	159
2019 Q4	$244K	Buy	+752	New	+$228K	0.12%	177

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LexAurum Advisors's TMO Position: Q2 2026 in Review

LexAurum Advisors reduced its Thermo Fisher Scientific (TMO) stake by 42% in Q2 2026, selling an estimated $138K and leaving 405 shares worth $203K. The position accounts for 0.02% of the portfolio, ranked #408.

LexAurum Advisors first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $502K in Q4 2021. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

LexAurum Advisors held 405 shares of Thermo Fisher Scientific worth $203K as of Q2 2026.
LexAurum Advisors sold 288 Thermo Fisher Scientific shares in Q2 2026, an estimated $138K.
Thermo Fisher Scientific made up 0.02% of LexAurum Advisors's portfolio in Q2 2026, its #408 holding.
LexAurum Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
LexAurum Advisors's Thermo Fisher Scientific position peaked at $502K in Q4 2021.
2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.